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Trypanosoma brucei stress response 
protein kinases required for survival 
in the mouse
Fernando Fernandez-Cortes  ?, Tiago D. Ƥ  ?ǡ ?, Jonathan M. Wilkes  ?, Nathaniel G. 
Jones  ?ǡ ?, Ryan Ritchie ?, Richard McCulloch  ? & Jeremy C. Mottram  ?ǡ ?
Protein kinases (PKs) are a class of druggable targets in Trypanosoma brucei, the causative agent of 
Human African Trypanosomiasis (sleeping sickness), yet little is known about which PKs are essential 
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PKs are also potential virulence factors essential in vivo, lines were pooled, inoculated into mice, and 
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defect in vivo, than in vitro. Amongst these PKs were several with putative functions related to stress 
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provides new insights into T. brucei-host interaction and reveals novel potential protein kinase drug 
targets.
Trypanosoma brucei is an obligate parasite in the class kinetoplastida, a group of lagellated protozoa character-
ized by a dense complex of circular mitochondrial DNA called the kinetoplast. T. brucei spp infect humans and 
animals in sub-Saharan Africa, causing diseases that remain major threats to health and economies in the region. 
T. brucei exhibits a complex life cycle that requires adaptation to many diferent environments, including diferent 
compartments within the blood-feeding insect vector responsible for transmission between diferent mammalian 
hosts: the tsetse ly. Once in the mammal, T. brucei resides extracellularly in the bloodstream, tissue luids, cen-
tral nervous system and adipose tissue1. Bloodstream T. brucei undergo antigenic variation and express a single 
Variant Surface Glycoprotein (VSG) per cell, which can be switched upon expansion of the population to create 
diversity2. he host builds an adaptive immune response against at least the most abundant variants, leading to 
their clearance and enabling outgrowth of cells that have switched to an antigenically distinct VSG. Iteration of 
this process leads to the characteristic waves of parasitemia3.
Protein kinases (PKs) are key signalling proteins in eukaryotes, playing critical roles as central regulators in 
many biological functions, as well as being validated drug targets. he T. brucei protein kinome represents 2% 
of the parasite’s protein-coding capacity and comprises 157 conserved eukaryotic PKs (ePKs), 12 non-catalytic 
pseudokinases and 20 atypical PKs (aPKs)4–6. Substantial diferences exist between the T. brucei and the human 
protein kinomes, as the parasites lack receptor-linked tyrosine kinases and tyrosine-like kinases. Despite this, 
tyrosine phosphorylation has been reported, possibly due to dual-speciicity kinases4, 5. T. brucei also has a 
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relatively reduced representation of AGC and CAMK families, while CMGCs, STEs and NEKs are comparatively 
expanded. In addition, several highly divergent PKs are likely to play parasite-speciic functions that may present 
targets for selective inhibition by small molecules4, 5.
PKs are a promising source of druggable targets, with more than 100 inhibitors already in clinical trials and 
successful drugs in the market, such as the prototypical compound Imatinib® for chronic myeloid leukemia7. 
Several high-throughput screening campaigns with compound libraries have been published linking in vitro tryp-
anocidal activity with PK inhibition8–10, though the speciic PK target in each case is unknown. Over 40 T. brucei 
PKs have been shown to be essential for normal cell proliferation in vitro6, 11. Many biological roles for PKs have 
been revealed in T. brucei, but they have been observed mainly in the artiicial conditions of in vitro culture. In 
this paper we use a kinome-focused RNAi library in a 72 h mouse infection model to address a key question of 
both biological and pharmaceutical relevance: which PKs are required for survival of the parasite in the environ-
ment of the mammalian bloodstream?
Results
Kinome-wide in vitro and in vivo RNAi screens. We had previously generated a collection of individ-
ual T. brucei RNAi cell lines to identify PKs essential for proliferation of bloodstream form parasites in culture, 
cell cycle regulators and negative regulators of BSF to PCF diferentiation6. In order to increase the capacity for 
screening the kinome RNAi library, we made a pool of the 177 available cell lines, which targeted 183 of the PKs 
(6 were double knockdowns)6. his pool allowed parallel phenotyping of the population in a single culture (in 
vitro) and in a single mouse (in vivo) through RNAi target sequencing (Fig. 1). Cytocidal or cytostatic phenotypes 
were identiied by a quantitative reduction in the reads mapping to a particular RNAi target in the induced sam-
ples (tet+) relative to their expanded representation in the uninduced (tet−) controls.
For both the in vitro and the in vivo experiments, the reads were iltered to include only those that contained 
a 9-nucleotide tag encoded in the PCR primers and were then mapped against the sequences of T. brucei PK 
ORFs. Ratios were determined from the reads that mapped to each PK gene in the induced sample relative to the 
uninduced sample (and in the uninduced relative to the pre-inoculation pool) with a bootstrap analysis including 
Figure 1. In vitro and in vivo phenotyping of a T. brucei kinome RNAi library. Schematic representation of 
the experimental worklow. (A) A pre-inoculation pooled kinome RNAi library was diluted to contain 1 × 105 
cell ml−1 in 100 ml and grown in culture for 24 h in triplicate. Each culture was then split into two lasks, one in 
which RNAi was induced with tetracycline (Tet+) and the other remained uninduced (Tet−). 1 × 107 cells were 
sampled every 24 h over 5 days for DNA puriication and cultures diluted daily to contain 1 × 105 cells ml−1.  
(B) 5 × 104 T. brucei bloodstream form parasites of the pooled kinome RNAi library were injected 
intraperitoneally into 12 CD1 mice and 24 h post inoculation, RNAi was induced with doxycycline in 6 animals 
(Tet+ 1–6) and 6 were let uninduced (Tet− 1–6). 48 h post RNAi induction, parasites were puriied from blood 
and genomic DNA prepared. (C) PCR enrichment of the RNAi target was carried out. he cropped gel example 
shows RNAi target distribution in 4 diferent samples: Tet− (1), Tet+ (2), a single cell line control (3), and the 
preinoculation pool (4). he experiment was performed twice and PCR-enriched samples from each biological 
replicate were sequenced. A full-length gel is presented in Figure S5.
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1000 repeats, which enabled calculation of the median and estimation of 95% conidence intervals for each gene 
(Data sets S2–S3). Ratios under 0.6 were considered loss of itness phenotypes based on the scores for the PK with 
an upper limit for the 95% conidence interval under 0.75 in the biological replicates performed in vivo. When 
the 0.6 (induced/uninduced) threshold was applied to the in vitro data set it was determined to be discriminatory, 
showing a progressive increase of the number of targets identiied with time (Fig. 2A), and a comparable proile 
in the in vivo dataset (Fig. 2B).
For the in vitro RITseq screen, the results of read mapping (Data sets S1 and S2) show an increase with time 
of both the number of PKs that displayed loss of itness (as deined by induced/uninduced ratios < 0.6, Fig. 2A), 
and the extent of loss of individual PKs from the population (Data set S1). Comparing the in vitro screen with 
available data in the literature, 38 out of the 47 lines found at the 72 h time point had also been identiied in the 
72 h in vitro Alamar blue screen performed by Jones et al.6 with the same cell lines (Fig. 2C). Overlap with the 
genome-wide RITseq.12 was less pronounced, with only 18 of the PKs identiied in this study being detected, 
notably those with the most deleterious growth phenotypes.
he in vivo experiment was repeated to provide two biological replicates, with the PCR products barcoded, 
multi-plexed and sequenced using two diferent platforms: Ion TorrentTM and Illumina®. A total of 157 RNA cell 
lines were detected in the irst in vivo experiment, meaning 24 cell lines were missing, possibly due to loss of indi-
vidual cell lines during ampliication of the pre-inoculation pool. he missing PK RNAi cells were remade and 
added to the second experiment, enabling detection of 177 PKs. Four PKs were excluded from the analysis due to 
Figure 2. Intrinsic reproducibility and correlation between in vivo and in vitro RITseq. (A) Bootstrap median 
ratios of uninduced/input (Tet−/input) and induced/uninduced (Tet+/Tet−) in triplicate for each time point of 
the in vitro RNAi screen, arranged in increasing order. Reads were normalized as reads per million (RPM).  
(B) Bootstrap median ratios of uninduced/input (Tet−/input) and induced/uninduced (Tet+/Tet−) of each 
in vivo experiment arranged in increasing order. (C) Venn diagram showing the overlap between the number 
of loss-of-itness PK depletions identiied with the kinome-wide in vitro RITseq screen ater 72 h of RNAi 
induction and the two in vitro studies covering the PKs of T. brucei available in the literature6, 12 at the same time 
point. (D) Bootstrap medians of ratios calculated between induced and uninduced in vivo samples plotted per 
RNAi target assessing regression of both biological replicates. Highlighted in red are those with a loss of itness 
in the two experiments, in black those with a loss of itness in one only, and blue those without a loss of itness. 
(E) Breakdown of results for loss of itness RNAi lines within each of the individual in vivo biological replicates. 
Depicted average and range of normalized counts for the 6 mice analyzed per condition (Tet+ or Tet−) and per 
RNAi target. (F) As panel D but focusing on the RNAi cell lines giving a loss of itness (ratio < 0.6) in at least 
one of the 2 biological replicates. Includes depicted correlation with the in vitro screen previously published by 
Jones et al.6 with the same library (slow growth, cell cycle arrest or death), highlighting PKs whose depletion 
produced loss of itness only in vivo.
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low abundance in the initial inoculum, which made assignment of reads inaccurate (Data set S3). Analyzing the 
in vivo data based on the 0.6 induced/uninduced threshold, 53 PK genes were identiied that showed a relative 
depletion of reads in the induced samples, indicating a loss of itness 48 h ater RNAi induction in one or both of 
the experiments. Forty genes showed such loss of itness in both of the biological replicates (Data set S1), with 
six seen only in Experiment 1 and eight only in Experiment 2 (six of which were absent in the irst experiment).
Linear regression across the two in vivo experiments showed good reproducibility for the complete dataset 
(R2 = 0.77; p < 0.0001, Fig. 2D), and substantially better if only the 49 RNAi targets with an average induced/
uninduced ratio < 0.6 between the 2 biological replicates were compared (R2 = 0.82; p < 0.0001, Fig. 2D). he 
regression value for cell lines with itness ratios over the 0.6 threshold decreased to R2 = 0.22. he intrinsic repro-
ducibility across mice for both uninduced and induced groups per gene identiier was also excellent within the 
two biological replicates (see means and ranges displayed in Fig. 2E). hirty-ive out of 42 RNAi lines displaying 
loss itness in the Jones screen also had a loss of itness in vivo, with the most pronounced ‘death’ or ‘cell cycle 
arrest’ phenotypes in vitro also having the most signiicant loss of itness in vivo (Figs 2F and S1A). Among the 
seven RNAi lines displaying signiicant loss of itness in vitro but not in vivo, six were classiied as “slow growth” 
and they only had signiicant growth retardation ater 72 h of RNAi induction, which would not have been appar-
ent in the 48 h timescale of the in vivo screen. In order to validate the observed correlation between the published 
in vitro loss-of-itness phenotypes and those observed in vivo, growth analysis of 4 cell lines showing no growth 
defect or slow growth, growth arrest or death (as deined in ref. 6) were performed (Fig. S1B). A good correlation 
was observed between the in vitro growth and the median ratios of induced/uninduced for the in vivo RITseq. 
Comparing the PKs that showed loss of itness in vitro and in vivo revealed notable overlap, though it was clear 
that there was a delay in the manifestation of loss of itness in vitro when compared with the in vivo infection 
(Fig. S1C).
Classification of protein kinases required for optimal growth in vivo ? ?-
tion. he 49 PKs whose depletion caused an in vivo loss of itness are distributed across all the major PK fam-
ilies (Fig. 3 and Data set S1). here are 40 ePKs, 7 aPKs and 2 putative pseudo-kinases. Two ePKs and one of the 
pseudo-kinases are considered “orphan” (without clear identity with known orthologues in Saccharomyces cerevi-
siae, Caenorhabditis elegans, Drosophila melanogaster or Homo sapiens) and are likely to be kinetoplastid-speciic. 
All of the 49 PKs have orthologues in either Leishmania major or Trypanosoma cruzi or both, though with vari-
able levels of sequence identity between the kinetoplastid parasites (Figs 3 and S2, Data set S1). hirty-ive of the 
PKs that were identiied in the Alamar blue kinome-wide RNAi screen have been discussed previously6, and so 
details will not be provided here. hree of these genes were identiied in the whole-genome RITseq.12: PLK1 and 
KKT2, which have been shown to be essential in other studies13, 14, and AUK2, which only showed a loss of itness 
in vitro ater 120 h of induction (Data set S1). Another PK with proven kinase activity, Tb927.10.14770 (CAMK, 
AKB1) has been reported to downregulate cytokinesis and cell division if overexpressed or downregulated15.
Ƥin vivo than in vitro. here were 12 PKs 
identiied with a signiicant loss of itness in vivo that were not reported in the in vitro alamar blue screen per-
formed previously6, suggesting an important role for survival in the mammalian bloodstream. Two of these RNAi 
PK lines, targeting AKB1 and MRK1, were found to be missing from the original library. AKB1 depletion has 
been shown to result in a loss of itness in vitro15, however, both AKB1 and MRK1 depletion show a defect only 
ater 96 h of RNAi induction in culture (Fig. 3). In contrast, AUK2 has been reported to have a loss of itness in 
the whole genome RITseq screen12. While required in vivo from 48 h onwards, AUK2 did not show a phenotype 
until 120 h of induction in vitro. CAMKL showed loss of itness from 48 h onwards and four other PKs from 
72 h onwards: Bud32, VPS15, DYRK1 and CK2A2. SRPK1 showed loss of itness from 96 h, whilst PLK-like and 
FAZ20 ater 120 h. he only PK that did not show an in vitro phenotype at all was STE11/Bck1p.
In order to add an extra layer of validation, independent growth curves were performed in culture for individ-
ual RNAi cell lines (Fig. S3). DYRK (Tb927.7.3880) had a clear growth defect ater 48 h of RNAi in vitro (Fig. S3A), 
and so this gene was not considered further. For the other PK genes, where no growth defect was detected ater 
48 h of RNAi induction in vitro, parasitemia was assessed for 72–96 h in mice, with or without induction of 
RNAi, ater inoculation of each individual selected cell line (Fig. S3B). Tb927.11.9290 (FAZ20), Tb927.2.1820 
(CAMKL), Tb927.11.850 (Bud32) and Tb927.11.9190 (VPS15) displayed some evidence for growth retardation 
ater RNAi in vitro (Fig. S3B) but, in each case, the extent of growth impairment or death was more pronounced 
in vivo. For each of the remaining six cell lines there was no evidence of RNAi-induced growth retardation in 
vitro. Two of the lines, targeting Tb927.3.3920 (AUK2) and Tb927.10.10350 (STE11/Bck1p), experienced growth 
retardation in vivo from 48 h, indicating a loss of itness. For three other genes, Tb927.2.2430 (Other/CK2A2), 
Tb927.7.960 (CMGC/SRPK1) and Tb927.10.14300 (STE11/MRK1), the loss of itness ater in vivo RNAi was even 
more pronounced, since a decrease in parasitemia or clearance was seen before 96 h (Fig. S3B).
Taken as a whole, these growth curves validate the kinome-wide RITseq both in vivo and in vitro for nine of 
twelve PKs predicted to play a more important role in the mammalian infection than in in vitro culture.
Ǥ One of the most obvi-
ous and distinctive elements encountered by parasites during infection in mice when compared with in vitro 
culture conditions is the exposure to mammalian serum factors, with the VSG coat providing protection 
against complement-mediated lysis3. To test if loss of potential PK virulence factors might impede survival in 
the presence of serum, we exposed PK RNAi lines shown to be defective in DNA repair (Stortz et al.16, manu-
script in press) to fresh rat serum for 3 h (10% and 50% concentration) and analyzed relative survival of RNAi 
induced and uninduced cells when compared to controls that were not exposed to rat serum (Fig. 4A). In 
addition, we tested Tb927.7.3880 (DYRK) that was found to produce a growth defect both in vivo and in vitro. 
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Uninduced cells showed an increase in survival as serum concentration increased. RNAi against Tb927.7.3880 
(DYRK), which caused impaired cell growth in vitro, caused no serum sensitivity. In contrast, RNAi against 
Tb927.2.1820 (CAMKL), Tb927.3.3920 (AUK2) and Tb927.7.960 (CMGC/SRPK1) resulted in significant, 
concentration-dependent sensitivity to serum, manifest in survival rates 50% lower than the equivalent unin-
duced samples. To understand whether such sensitivity was due to complement-mediated lysis, these three cell 
lines -RNAi induced and uninduced- were further exposed to 50% serum complement-inactivated with 20 mM 
EDTA17. For Tb927.2.1820 (CAMKL) and Tb927.7.960 (CMGC/SRPK1), the EDTA treatment ablated the serum 
sensitivity, strongly suggesting that the RNAi phenotype was due to increased complement-mediated killing. 
AUK2, however, was more diicult to interpret as Tet− cells showed increased survival when EDTA was added.
Two MAP3K PKs (Tb927.10.14300 and Tb927.10.10350) have a signiicantly more pronounced loss of itness 
phenotype in vivo than in vitro (Fig. S3); these have sequence identity to yeast PKs that regulate osmotic stress 
(Data set S4). To test whether they might be involved in resistance to osmotic changes encountered during cir-
culation in the mammalian host, a ‘Swell dialysis’ assay was performed18. Controlled bufering conditions were 
used to produce mildly turgid cells and assess how RNAi-induced cells survived gentle osmotic shock compared 
with uninduced controls (Fig. 4B). RNAi against each predicted STE11 PK resulted in a statistically signiicant 
Figure 3. Heatmap depicting 49 cell lines showing loss of itness during in vivo RNAi and their corresponding 
in vitro RNAi phenotypes. An individual PK from the library is represented in each row and they are grouped 
by family; those appearing in bold font were not identiied as showing loss of itness by in vitro Alamar blue 
screening6. he 0 h column is artiicially adjusted to a solid colour representing a baseline value, the remaining 
heatmap columns represent the actual mean RIT-seq value determined at each time point up to 96 h in vitro 
and the 48 h in vivo time point. Lighter shades represent the reduction in the RIT-seq value and thus the loss of 
a cell line from the library. HAT Box Target? refers to a protein kinase that is a potential target for compounds in 
the GSK HAT Box by phylogenetic orthology to a human PK targeted by a compound in the box8. he L. major 
and T. cruzi columns use a circle to denote if an orthologue of the T. brucei gene encoding the protein kinase is 
present in the respective organism (see Data set S1).
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reduction in cell survival in these conditions. RNAi of Tb927.10.14300 resulted in a 20% reduction in cell viability 
ater osmotic shock at both 48 h and 72 h ater RNAi induction. Ablation of Tb927.10.10350 resulted in a much 
more severe phenotype, with a 50% reduction in cell viability ater osmotic shock at 48 h and 72 h ater RNAi 
induction.
Discussion
In this study we aimed to deine the cohort of protein kinases that are essential for T. brucei to survive in the mam-
malian bloodstream. We modiied whole-genome parallel phenotyping based on RITseq technology12 and applied 
it to a deined collection of individually designed and validated RNAi cell lines. his method was used to analyze 
in vitro and in vivo experiments to permit the identiication of 49 essential PKs, including 9 PKs that appear more 
important for survival in the environment of the mammalian circulatory system than in culture. Bioinformatic 
assessment of each gene suggested these PKs are involved in parasite stress-response pathways. Validation of 
individual cell lines identiied PKs that play roles in protecting the parasite from mammalian serum factors and 
osmotic stresses. Our indings expand the repertoire of essential and potentially druggable PKs in this pathogen 
and begin to explore the mechanisms by which the parasite survives the multiple stresses of life inside its host.
he adaptation of genome-wide RITseq technology to smaller, deined libraries was advantageous for in vivo 
experiments for several reasons. he coeicient of determination between the induced/uninduced read mapping 
ratios obtained between the two experiments was very good, especially when focused on those with a loss of 
itness RNAi phenotype (Fig. 2F). Intrinsic reproducibility across diferent mice within the same experiment 
Figure 4. Survival when exposed to serum or osmotic shock. (A) Parasites at 106 cells ml−1 were exposed for 3 h 
to rat serum (10% and 50% concentration). Relative survival was measured for induced (tet+, 72 h RNAi) and 
uninduced (tet−) clones compared to no-serum controls. Where deicient survival was detected in tet+, ater 
addition of tet, cells were exposed to 50% serum complement-inactivated with 20 mM EDTA. (B) Cells were 
subjected to an osmotic shock protocol and survival of the induced cells (tet+, 48 h and 72 h RNAi) compared 
to uninduced (tet−) was plotted. *p < 0.05, using paired T-test.
www.nature.com/scientificreports/
7SCIENTIFIC REPORTSȁ ?ǣ 6 1 5 6  ȁǣ ? ?Ǥ ? ? ? ?Ȁ ? ? ? ? ?Ǧ ? ? ?Ǧ ? ? ? ? ?Ǧ ?
was also excellent (Fig. 2E). Inclusion of a single clone per RNAi target may allow an advantage in terms of 
phenotypic homogeneity compared with strategies where a pool of RNAi vectors are transfected into parasites 
to generate an unknown number of clones per target with diferent levels of depletion ater induction. We show 
that focusing RITseq to smaller libraries6 enhances resolution of the loss of itness readout enabling a ~1000-fold 
increase in sequence read depth in comparison to the whole genome screen (Fig. S4). his increase in resolution 
meant that we were able to detect 56 PKs that result in a loss of itness upon depletion with the kinome-library 
in vivo or in vitro, while only 19 of these PKs with the most severe growth defects (Data set S1) were identiied 
in a whole-genome library RITseq screen that assessed loss of itness in culture ater 3 days of RNAi induction12 
(Fig. S1A). Importantly for this study, reduced library size and associated RITseq resolution allowed a 72 h in vivo 
model of infection in mice, which would not have been possible with the larger parasite numbers required to 
cover the whole genome. Although whole genome RITseq screens may have lower resolution, they assess in paral-
lel all the protein families, thus being a valuable tool to identify pathways and networks whose activity is required 
under any selective pressure or culturing condition.
Trypanosomes are highly adaptable organisms, capable of withstanding immune assault by the host and 
responding to the many changing conditions they experience during their life cycles, including temperature, pH, 
osmotic imbalance, shear-forces, and availability of carbon and nitrogen sources. his study reveals that depletion 
of at least nine PKs limits the capacity of T. brucei to replicate in the mouse bloodstream, while the same cells 
remain more competent for growth in culture, suggesting roles for the PKs as virulence factors required to over-
come challenges encountered only in vivo. he precise functions provided by the PKs remain to be identiied, but 
a common theme from sequence-based functional predictions is the management of stress. It has been shown in 
bacteria that, in addition to ‘direct’ or sensu stricto virulence factors (such as toxins or invasins), elements involved 
in stress management are also ‘indirect’ or ‘contributory’ elements required for establishment of the infection19. 
A connection between stress resistance and virulence has also been found for many other infectious eukary-
otic organisms20–24, including Leishmania25, 26. Sequence similarity between eight of the T. brucei in vivo-speciic 
PKs and kinases in other eukaryotes suggests diverse functions, including gene expression, alternative splicing, 
protein synthesis and translational regulation in response to extracellular signals, and stress adaptation linked 
with autophagosome formation (Data set S4). One of the nine PKs difered from the rest, in that it appears to 
be a highly divergent, putative pseudo-kinase (Tb927.11.9290/FAZ20), since it lacks several of the key residues 
and subdomains required to be an active PK27. Previous work has shown that this PK localizes to the tip of the 
lagellum attachment zone in both the old and the new cell generated during cytokinesis28, perhaps suggesting 
parasite speciic functions. Two MAP3K (STE11) PKs were identiied amongst the in vivo cohort. Tb927.10.14300 
(STE11/MRK1) has features in common with members of the yeast High Osmolarity Glycerol (HOG) path-
way, which responds to osmotic challenge through actin recovery29, while the MORN motifs-containing protein 
Tb927.10.10350 (STE11/Bck1p) resembles human MEKK3, a positive regulator of the stress-activated protein 
kinase (SAPK) pathway30 putatively involved in cell integrity maintenance under stress conditions. he increased 
susceptibility to osmotic shock seen ater RNAi induction of these two STE11 PKs (Fig. 4B) indicates that they 
may provide similar roles in Trypanosoma brucei. While human plasma is considered by convention isotonic, 
many tissues are exposed to osmotic luctuations both physiological and triggered by inlammation for which 
all cells, including infectious pathogens, need to be prepared31. Immediate downstream interaction partners of 
STE11s (STE7s) were not identiied in this screen, which may suggest redundancy amongst the T. brucei STE7 
cohort, or perhaps a non-canonical mode of action for the T. brucei STE11 PKs. Two other MAPKs (ERK-like), 
oten involved in transcriptional and non-transcriptional regulation in response to external stimuli, were found 
to be essential both in vivo and in vitro: KFR1, previously reported to be regulated by interferon γ in order to 
promote proliferation in T. brucei32; and MAPK6 (ERK8), which regulates cytokinesis33.
hree PKs that have a pronounced loss of itness in vivo cluster together within the PI3K/TOR pathway: 
Tb927.11.9190 (VPS15), Tb927.11.850 (Bud32) and Tb927.7.960 (SRPK1). VPS15 is required for stress-induced 
and developmentally-triggered autophagosome formation in other eukaryotes and assembles within the PI3K 
complexes34. PI3K signalling in yeast involves Bud32 (orthologues called PRPKs in humans and Drosophila), 
which acts as a transducer for TOR activation that, in turn, has also been related with autophagy and endocyto-
sis under stress conditions. SRPK1 regulates splicing factors in response to stress and can be activated via PI3K 
signaling in other eukaryotes35. he identiication of these TOR-related PKs is of interest, because TOR path-
ways are central for parasite-host interaction in T. brucei36. While most eukaryotes encode two TOR paralogues, 
trypanosomatids are the only known organisms to contain four, each integrated in a diferent protein complex, 
of which three are required for normal itness both in vivo and in vitro (this study and ref. 6). TbTOR1 regulates 
transcription and translation and its depletion leads to autophagy, thereby enhancing survival upon nutritional 
stress, which is linked to developmental progression37. TbTOR2 is required for actin polarization, which in turn is 
essential for secretion and endocytosis37, 38. TbTOR3 responds to osmotic shock by control of polyphosphates and 
acidocalcisomes39, organelles that are crucial for autophagy in T. brucei40. he last paralogue, TbTOR4, is required 
for T. brucei proliferation and life stage maintenance in bloodstream forms as its depletion triggers diferentiation 
from replicative slender to stumpy cell-cycle-arrested forms41. How the three in vivo only PKs identiied here 
might act within the expanded PI3K/TOR signaling network awaits further analysis.
It is intriguing that three PKs with a pronounced loss of itness in vivo, AUK2, CAMKL and SRPK1, have 
also been identiied in a companion RNAi screen for factors required for T. brucei to withstand or repair damage 
caused by alkylation in vitro (Stortz et al., submitted). he three showed an increased sensitivity to serum upon 
RNAi induction, related to complement-mediated lysis. In what way, if at all, the two phenotypes might overlap is 
unclear but the potentially common function of each T. brucei PK in providing serum resistance (Fig. 4A) might 
guide future studies, and at least one (AUK2) clearly has a role in genome maintenance (Stortz et al., manuscript 
in preparation). he inal gene that is only essential for in vivo growth, CK2A2, has validated protein kinase 
activity and localizes primarily to the nucleolus42. CK2 is mainly controlled by distribution and abundance, with 
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stress-induced mobilization extensively reported43. CK2 has also been associated with autophagy through inter-
section with PI3K/AKT/TOR and MAPK pathways44.
T. brucei protein kinases are druggable45 and this work provides genetic validation for 49 protein kinases that 
are required for in vivo itness. A phylogenetic comparative analysis between the T. brucei and Homo sapiens 
kinomes showed that 13 out of the 49 PKs had close human orthologues targeted by at least one of the compounds 
in the ‘HAT box’ (Fig. 3, data set S1 and ref. 8). Targets identiied in this screen open an opportunity to develop 
drug repurposing strategies, as has been already suggested for aurora kinases46 and PI3K/TOR kinase inhibi-
tors47. All of the 49 PKs important for T. brucei growth have close orthologues in either T. cruzi, L. major or both 
(Fig. S2). Extrapolation of results based on gene ontology using T. brucei as a model may be valuable to identify 
potential trypanosomatid-wide drug PK targets48, since to date these organisms lack eicient reverse genetics 
tools for kinome- or genome-wide studies.
Materials and Methods
Ǥ Animal procedures followed the guidelines and were approved by he Home Oice 
of the UK government. he procedures here presented were covered by the project license PPL60/4442 enti-
tled “Molecular Genetics of Trypanosomes and Leishmania”. he University of Glasgow ethics committee also 
approved all protocols.
Parasite maintenance. Monomorphic Trypanosoma brucei brucei 2T1 bloodstream forms49 were cultured 
in HMI-11 [HMI-9 (GIBCO) + 10% v/v foetal bovine serum (GIBCO), Pen/Strep solution (penicillin 20 U ml−1, 
streptomycin 20 mg ml−1)] at 37 °C/5% CO2 in vented lasks. Selective antibiotics were used as follows: 0.2 µg ml
−1 
puromycin, 0.5 µg ml−1 phleomycin (InvivoGen), 2.5 µg ml−1 hygromycin B (Calbiochem). RNAi was induced in 
vitro with tetracycline (Sigma Aldrich) in 70% ethanol at 1 µg ml−1.
To test for serum resistance 200 µl of log-phase parasites in HMI11 at 106 cells ml−1 were exposed to fresh rat 
serum for 3 h (10% and 50% concentration). Relative survival was measured of induced (for 48 h) and uninduced 
clones compared to no-serum controls. he whole experiment was performed in triplicate.
To test for response to osmotic shock18 2 × 106 cells were resuspended for 5 min at 4 °C in 0.5 ml of a solution 
55 mM KCl/1 mM glucose to induce cell swelling. 0.5 ml of a 263 mM KCl/1.75 mM Mg2Cl shrinking solution was 
added on top and cells incubated for 5 min at 4 °C. Remaining cells were washed once and resuspended in 1 ml 
of HMI11 media before counting. Survival of the induced cells compared to uninduced controls was plotted and 
signiicant results (p < 0.05) ater T-tests indicated with a star.
RNAi library. All RNAi cell lines in this work were generated as previously described6. RNAi lines were 
pooled into 9 ‘Mixed Stabilate Trypanosome Libraries’ (MSTL 1–9), each containing 19–25 cell lines. hen MSTLs 
were further pooled to make the inal culture.
he library used for the in vitro RITseq was defrosted, grown for 24 h and diluted to contain 1 × 105 cells ml−1 
in 100 ml. In triplicate the culture was split into two 50 ml lasks (tetracycline induced and uninduced control) 
and grown for 120 h, reducing cells to 1 × 105 cells ml−1 every 24 h. 1 × 107 cells were sampled daily for analysis.
Animals and in vivo growth analysis. Female CD1 outbred mice (6–8 weeks old) were obtained from 
Charles River (Edinburgh, Scotland). Animals were given water and food ad libitum. Infections were performed 
by intraperitoneal injection and were evaluated daily by assessing parasitemia levels with a hemocytometer by tail 
vein sampling diluting blood in anticoagulant (CBSS/Heparin) 0.83% w/v. If parasitemia exceeded 108 cells ml−1 
mice were euthanized with carbon dioxide and cervical dislocation. RNAi was induced in mice with doxycycline 
hyclate (Sigma Aldrich) added in sugared drinking water (0.2 g/L plus 50 g/L sucrose). For the in vivo RITseq, 
blood from euthanized mice 72 h ater infection was collected and immediately applied to DEAE-cellulose col-
umns as described50. DNA was isolated from the parasites using a QIAamp DNA kit (Qiagen, Venlo, Netherlands).
RNAi Target sequencing. he library pool used at Experiment 1 was the product of mixing MSTLs 1–8. A 
single universal cassette-speciic primer (5′-TAATGCCAACTTTGTACAAA-3′) was used to PCR enrich RNAi 
inserts ampliied from 10 ng of genomic DNA obtained per sample in a 50 µl reaction using Q5® High-Fidelity 
DNA polymerase (NEB, Ipswich, USA). he PCR program was: 3 minutes at 98 °C; followed by 28 cycles com-
prising: 10 seconds at 98 °C, 10 seconds at 61 °C and 30 seconds at 72 °C; with a inal extension step at 72 °C for 
10 minutes. PCR products were cleaned up with Minielute PCR puriication kit (Qiagen, Venlo, Netherlands), 
400 ng of DNA per sample were fragmented, size selected (average read length ater sequencing ~106 nucleo-
tides) and processed according to Ion Torrent library prep protocols. he multiplexed sample was subjected to 
emulsion PCR and Ion Torrent sequencing. he library pool used at Experiment 2 was processed as above with 
the following exceptions, a mix of MSTLs 1–9, PCR annealing temperature was elevated to 64 °C, as additional 6 
nucleotide-long labels were added to the single universal primers (list of oligonucleotides and multiplex distribu-
tion in Data set S5) enabling pooling of the samples and usage of a single commercial barcode.
Ǥ Artiicial chromosomes were generated in silico by concatenating the 183 amplicons 
representing all the RNAi targets included in this study, joining the 3′ end of one with the 5′ end of the next using 
a bufer sequence of 15 random bases. he coordinates of each sequence were recorded. he artiicial chromo-
some sequences were indexed for use in Bowtie2 (short-read alignment sotware)51, using default parameters. For 
in vivo Exp.1, single end reads generated from each sample were selected by the presence of a 9 base diagnostic 
tag [GCCAACTTT] present within the universal primers, permitting 1 mismatch (insertion, deletion or substi-
tution). Approximately 20% of the reads contained the RNAi cassette. For in vivo Exp.2 and in vitro RITseq, single 
end reads were identiied and clustered according to 6 base-long barcodes before being processed as in Exp.1 
(without the fragmentation/size selection step) inding 65–70% of reads containing the RNAi target. Selected 
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reads were mapped to the artiicial chromosomes with Bowtie2 (aligning in local mode). he “.sam” format iles 
generated by Bowtie2 were parsed and the coordinates of the appropriate chromosome to which the read mapped 
were recorded. he mapped reads were assigned to the appropriate PK sequence by reference to the index gener-
ated above. he read was assigned if it lay entirely within the PK sequence or overlapped the 3′ or 5′ end of the PK 
sequence. In each replicate, accumulated read abundances were normalized by multiplying raw counts 106 times, 
dividing by the sum of total valid reads accepted for the analysis in the whole sample and rounding to the next 
integer, i. e. reads per million (RPM). Bowtie2 mapping was used also to compare whole-genome/kinome-wide 
RITseq coverage as depicted in Fig. S2.
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